Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Dexcom has submitted an application for the 15-day sensor to the Food and Drug Administration for clearance. Using technology to manage Type 2 diabetes was also a focus at the conference.

DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

now is the time to push for greater investment in CGM technology as a core component of Type 2 management,” Adrian Gut, Dexcom’s senior director of international access, advocacy and value ...

Dexcom State of Type 2 Report: Access and Attitudes Across ... new Dexcom G7 15 Day sensor1 will be presented on March 20 at 1 p.m. CET in Hall D. With a MARD of 8.0%,2 Dexcom G7 15 Day will ...